loader from loading.io

Global Rhythm: US and European Atrial Fibrillation Guidelines Head-to-Head

Clot, Clot, Who's There?

Release Date: 05/28/2025

Conversations that count: Communicating with patients about anticoagulation show art Conversations that count: Communicating with patients about anticoagulation

Clot, Clot, Who's There?

Dr. Bethany Samuelson Bannow is joined by Dr. Erik Klok and Dr. Geoff Barnes for a discussion on the best ways to communicate with your patients about anticoagulation. Anticoagulation therapy is a cornerstone of care for patients, but starting and managing these medications can be overwhelming for patients. In this episode, we’ll cover common patient questions, tips for improving adherence, how to discuss lifestyle considerations and considering shared decision-making. Today’s episode is presented by the ISTH in partnership with Vasculearn Network. Vasculearn’s podcast “Clot, Clot,...

info_outline Global Rhythm: US and European Atrial Fibrillation Guidelines Head-to-Head show art Global Rhythm: US and European Atrial Fibrillation Guidelines Head-to-Head

Clot, Clot, Who's There?

Join Dr. Jose Joglar, Chair of the 2023 U.S. AFib Guidelines, and Professor Gregory Lip, Chair of the ESC Council on Stroke, as they dive into the latest U.S. and European atrial fibrillation guidelines. From risk scores to rhythm control, they explore common ground, key differences, and the global shift toward holistic, patient-centered care. (Hint: coffee lovers with AFib, rejoice!) Whether you’re a clinician navigating daily treatment decisions or a curious learner keeping up with cardiology guidelines, this is a must-listen conversation that reveals how far we’ve come in managing AFib...

info_outline Risky Business: Stratifying VTE and Managing Anticoagulation show art Risky Business: Stratifying VTE and Managing Anticoagulation

Clot, Clot, Who's There?

Join host Dr. Kerstin de Wit as she welcomes Drs. Cecilia Becattini and Behnood Bikdeli to unpack one of the most nuanced challenges in thrombosis care: venous thromboembolism (VTE) risk stratification and anticoagulation management. This case-based conversation explores:  How clinicians navigate decisions around continuing, reducing, or stopping anticoagulation Whether formal risk scores or D-dimer testing guide us—or just add noise The complexities of provoked vs. unprovoked VTE Approaches to shared decision-making Novel therapies on the horizon Tune in now and subscribe...

info_outline Sex as a Risk Factor for AF-related Stroke show art Sex as a Risk Factor for AF-related Stroke

Clot, Clot, Who's There?

Does sex influence the risk of atrial fibrillation (AF)-related strokes? Is female sex truly an independent risk factor? And what common myths still cloud clinical understanding? In this episode, host Dr. Giulio Francesco Romiti (internal medicine specialist from Sapienza University of Rome, Italy) is joined by guests Dr. Geoff Barnes (cardiologist and vascular medicine specialist, University of Michigan, USA) and Dr. Bernadette Corica (internal medicine specialist and cardiologist in training in Modena, Italy, and honorary research fellow at the Liverpool Centre for Cardiovascular...

info_outline The Burden of Atrial Fibrillation show art The Burden of Atrial Fibrillation

Clot, Clot, Who's There?

In this inaugural episode of Clot Clot Who’s There, global experts Professor Tatjana Potpara (Serbia), and Dr. Annabelle Volgman (USA) join moderator Dr. Panteleimon Papakonstantinou (Ireland) to discuss the rising global prevalence of atrial fibrillation (AF), a leading contributor to strokes and heart failure. They explore regional differences in AF management, evolving guidelines, and the potential of new treatments and technologies. With a focus on prevention, disparities in care, and the importance of early and individualized interventions, this discussion highlights critical pathways...

info_outline
 
More Episodes

Join Dr. Jose Joglar, Chair of the 2023 U.S. AFib Guidelines, and Professor Gregory Lip, Chair of the ESC Council on Stroke, as they dive into the latest U.S. and European atrial fibrillation guidelines. From risk scores to rhythm control, they explore common ground, key differences, and the global shift toward holistic, patient-centered care. (Hint: coffee lovers with AFib, rejoice!)

Whether you’re a clinician navigating daily treatment decisions or a curious learner keeping up with cardiology guidelines, this is a must-listen conversation that reveals how far we’ve come in managing AFib and where we’re headed next. 

Topics covered:

  • Point-of-care pathways 

  • Anticoagulation and evolving risk scores

  • Early rhythm control strategies

  • Addressing AFib as a cardiometabolic disease

  • Long-term impacts and future research priorities

Tune in now and subscribe to stay updated in expert insights in thrombosis and cardiovascular medicine!

For more resources, check out:

ESC Guidelines: Clinician Perspective: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-2434-9244
2024 ESC Guidelines: https://academic.oup.com/eurheartj/article/45/36/3314/7738779?login=false
2023 U.S. Guidelines: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001193

00:00 Introduction
01:57 Philosophies Behind AFib Guidelines
08:11 Lifestyle and Prevention in AFib
08:58 Evidence for Holistic Care: mAFA & MIRACLE Trials
12:34 Stroke Risk Scores and Future Research Needs
17:29 Rhythm vs Rate Control: Evolving Practice
20:56 Ablation, Drug Therapy, and Shared Decision-Making
22:12 The Caffeine Myth
24:31 Key Takeaways